Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1

Conditions

Health and Coping Undergoing Ovarian Cancer Surgery. 1Genital Diseases, Female 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Preoperative Care × Clear all
NCT03347409 2020-02-07

ERASGYNBS001

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Phase NA Completed
166 enrolled

Genital Diseases, Female

NCT01213771 2011-06-16

Health and Coping Prior to Ovarian Cancer Surgery

University of Aarhus

Phase NA Completed
279 enrolled
Gynecologic

Health and Coping Undergoing Ovarian Cancer Surgery.

Data powered by HemOnc (CC BY 4.0) Colophon âš¡